Multiple Myeloma (Case Study)
Anti-HER2 Mechanisms of Approved HER2 Inhibitors
Treatment goals in Essential Thrombocythemia and Polycythemia vera
An Approach to Diagnosis and Staging of MDS: From Morphology to Genetics
IBS-D: Pathophysiology and Treatment
When and how to intervene on the growing pulmonary nodule
IBD Pathogenesis: Personalizing Targets
The Hepatitis C Lifecycle
Confirming the Diagnosis, Extent, and Severity of IBD
Acute Myeloid Leukemia (Case Study)
Diagnosis and management of Hemophagocytic lymphohistiocytosis (HLH)
Management of Differentiated Thyroid Carcinoma in the Era of Targeted Therapy
Opening Lecture: Pitfalls in imaging for liver tumors
Stem Cell Transplant Approaches to MDS
Hypocellular MDS vs. aplastic anemia - Diagnosis and therapy
The WHO Updated Diagnostic Criteria for ET, PV & MF
Why is Hydroxyurea First Line Therapy in the US for Essential Thrombocythemia?
Understanding Iron Deficiency Anemia in Gastroenterology: Who and Why?
Emerging Therapies for Basal Cell Carcinoma - Lewis
HCC Whiteboard #2: The Mechanisms of Action of Tyrosine Kinase Inhibitors
Combating cachexia: New approaches
Management of appendiceal cancers: From pathology to treatment
Challenges in the treatment of severe Crohn's disease
Cytokines, Cells and Inflammation in MPN
Targeting the PI3K-Akt-mTOR Pathway
Targeting tumor protein 53 (p53): Is there anything we can do therapeutically?
Amyloidosis: Past, present, and future
How I approach the initial treatment of mantle cell lymphoma
CASE DISCUSSION: The hospitalized Ulcerative Colitis patient
The Biological Rationale for CDK4/6 Inhibitors
Immune Checkpoint Inhibitors in Hodgkin and non-Hodgkin Lymphoma
Screen discovered nodules: What next?
Atypical CML: Diagnosis and management
Multimodal management of patients with advanced cancer and cachexia
Bisphosphonates vs. RANK ligand inhibition in bone metastases
Update on dysplasia detection: Should you use chromoendoscopy?
Update on Long-acting Interferons for MPN
Next generation sequencing for the clinical oncologist: Demystifying the genomics black box
Treatment of Inpatients with Severe, Refractory Ulcerative Colitis
Case Discussion: The post-op Crohn's patient
Expert Perspectives: CDK 4/6 Inhibitors for ER+ Breast Cancer: Current Data and Clinical Use
How should we manage lymphocyte predominant Hodgkin lymphoma?
Use of Novel Prognostic Markers in Practice for CLL
Diagnostic challenges in MPN
Myeloma proliferation: A fresh look
Topical challenges in the management of ET
AML Treatment Challenges Who, When, and How
Use and misuse of endoscopy in patients with Crohn's disease
Update on vedolizumab in IBD: What have we learned?
Early Clinical Trials in HGF/C-MET Targeted Therapy - Dr. Johanna Bendell, Dr. David Spigel
Keynote Lecture 5: The value of whole body diffusion-weighted MRI for staging patients with CRC
What is new in bile duct cancer in the last 12 months?
Management of GIST tumors
Vitamin D in lymphoma therapy: What is its role and should we supplement?
Understanding non-response and loss of response in IBD: Which is it and when do we change classes?
Keynote Lecture: Managing Side Effects of IO Agents
Bone metastases: Role of zoledronic acid, denosumab and other strategies
